PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för NCX-4040. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

9 hits

Bibliografisk träff 2023-06-14

Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy.

Sinha BK, Bortner CD, Jarmusch AK, Tokar EJ, Murphy C, Wu X, Winter H, Cannon RE.

Cells · research support, n.i.h., intramural; research-article; journal article · DOI 10.3390/cells12121626

Bibliografisk träff 2022-12-31

Gene Expression Profiling Elucidates Cellular Responses to NCX4040 in Human Ovarian Tumor Cells: Implications in the Mechanisms of Action of NCX4040.

Sinha BK, Tokar EJ, Li J, Bushel PR.

Cancers (Basel) · research-article; journal article · DOI 10.3390/cancers15010285

Bibliografisk träff 2022-08-03

Molecular Mechanisms of Cytotoxicity of NCX4040, the Non-Steroidal Anti-Inflammatory NO-Donor, in Human Ovarian Cancer Cells.

Sinha BK, Tokar EJ, Bortner CD.

Int J Mol Sci · research-article; journal article · DOI 10.3390/ijms23158611

Bibliografisk träff 2021-04-02

NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells.

Sinha BK, Perera L, Cannon RE.

Cancers (Basel) · research-article; journal article · DOI 10.3390/cancers13071680

Bibliografisk träff 2020-10-01

A Drosophila model of Friedreich ataxia with CRISPR/Cas9 insertion of GAA repeats in the frataxin gene reveals in vivo protection by N-acetyl cysteine.

Russi M, Martin E, D'Autréaux B, Tixier L, Tricoire H, Monnier V.

Hum Mol Genet · research support, non-u.s. gov't; journal article · DOI 10.1093/hmg/ddaa170

Bibliografisk träff 2017-05-11

Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.

Madariaga-Venegas F, Fernández-Soto R, Duarte LF, Suarez N, Delgadillo D, Jara JA, Fernández-Ramires R, Urzúa B, Molina-Berríos A.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0176755

Bibliografisk träff 2015-10-25

NCX 4040, a nitric oxide-donating aspirin derivative, inhibits Prevotella intermedia lipopolysaccharide-induced production of proinflammatory mediators in murine macrophages.

Choi EY, Choe SH, Hyeon JY, Park HR, Choi JI, Choi IS, Kim SJ.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2015.10.032

Bibliografisk träff 2008-02-26

NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.

Bratasz A, Selvendiran K, Wasowicz T, Bobko A, Khramtsov VV, Ignarro LJ, Kuppusamy P.

J Transl Med · comparative study; research-article; journal article; research support, n.i.h., extramural · DOI 10.1186/1479-5876-6-9

Bibliografisk träff 2004-08-23

Nitroaspirins and morpholinosydnonimine but not aspirin inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells.

Muzaffar S, Shukla N, Angelini G, Jeremy JY.

Circulation · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1161/01.cir.0000139851.50067.e4